The logic is straightforward: lower bioavailability means less medication reaches the bloodstream per dose, so more frequent dosing compensates
Patients with pre-existing hypertension, arrhythmias, or coronary artery disease face elevated risk and require specialist oversight if dual therapy is considered
Lorenzo Leggio, a physician-scientist at the National Institutes of Health who wasnt involved in this study
Readers should confirm details directly with Elevate Health, the prescribing clinician, and the dispensing pharmacy
If someone has poorly controlled diabetes and their blood sugar levels are consistently high, they may experience frequent urination as a direct result
Additionally, cAMP and PKA phosphorylate ERK1/2, which controls genes involved in proliferative and anti-apoptotic processes, and activate several proteins, such as the mitogen activated protein kinase (MAPK) cascades [63]